Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial

Edouard Louis, Matthieu Resche-Rigon, David Laharie, Jack Satsangi, Nik Ding, Britta Siegmund, Geert D'Haens, Laurence Picon, Peter Bossuyt, Lucine Vuitton, Peter Irving, Stephanie Viennot, Christopher A Lamb, Richard Pollok, Filip Baert, Maria Nachury, Mathurin Fumery, Cyrielle Gilletta, Sven Almer, Shomron Ben-Horin, Yoram Bouhnik, Jean-Frederic Colombel, Erik Hertervig, Jane Andrews, Miles Sparrow, Rupert Leong, Susan Connor, Graham Radforth-Smith, Peter De Cruz, Jan Preiss, Andrea Stallmach, Thomas Liceni, Olaf Grip, Jonas Halfvarson, Dharmaraj Durai, Fraser Cummings, Christian Seilinger, Miles Parkes, James Lindsay, Guy Lambrecht, Philippe Van Hootegem, Jean-François Rahier, Marie Dewitte, Xavier Hebuterne, Elise Chanteloup, Romain Altwegg, Stephane Nancey, Guillaume Bouguen, Guillaume Pineton de Chambrun, Floriant Poullenot, Xavier Roblin

Open source

DOI: 10.1016/s2468-1253(22)00385-5
Published: 2023-03
Container: The Lancet Gastroenterology & Hepatology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-22-00385-5,
  title = {Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial},
  author = {Edouard Louis and Matthieu Resche-Rigon and David Laharie and Jack Satsangi and Nik Ding and Britta Siegmund and Geert D'Haens and Laurence Picon and Peter Bossuyt and Lucine Vuitton and Peter Irving and Stephanie Viennot and Christopher A Lamb and Richard Pollok and Filip Baert and Maria Nachury and Mathurin Fumery and Cyrielle Gilletta and Sven Almer and Shomron Ben-Horin and Yoram Bouhnik and Jean-Frederic Colombel and Erik Hertervig and Jane Andrews and Miles Sparrow and Rupert Leong and Susan Connor and Graham Radforth-Smith and Peter De Cruz and Jan Preiss and Andrea Stallmach and Thomas Liceni and Olaf Grip and Jonas Halfvarson and Dharmaraj Durai and Fraser Cummings and Christian Seilinger and Miles Parkes and James Lindsay and Guy Lambrecht and Philippe Van Hootegem and Jean-François Rahier and Marie Dewitte and Xavier Hebuterne and Elise Chanteloup and Romain Altwegg and Stephane Nancey and Guillaume Bouguen and Guillaume Pineton de Chambrun and Floriant Poullenot and Xavier Roblin},
  year = {2023},
  journal = {The Lancet Gastroenterology \&amp; Hepatology},
  doi = {10.1016/s2468-1253(22)00385-5},
  url = {https://doi.org/10.1016/s2468-1253(22)00385-5}
}

RIS

TY  - JOUR
TI  - Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
AU  - Edouard Louis
AU  - Matthieu Resche-Rigon
AU  - David Laharie
AU  - Jack Satsangi
AU  - Nik Ding
AU  - Britta Siegmund
AU  - Geert D'Haens
AU  - Laurence Picon
AU  - Peter Bossuyt
AU  - Lucine Vuitton
AU  - Peter Irving
AU  - Stephanie Viennot
AU  - Christopher A Lamb
AU  - Richard Pollok
AU  - Filip Baert
AU  - Maria Nachury
AU  - Mathurin Fumery
AU  - Cyrielle Gilletta
AU  - Sven Almer
AU  - Shomron Ben-Horin
AU  - Yoram Bouhnik
AU  - Jean-Frederic Colombel
AU  - Erik Hertervig
AU  - Jane Andrews
AU  - Miles Sparrow
AU  - Rupert Leong
AU  - Susan Connor
AU  - Graham Radforth-Smith
AU  - Peter De Cruz
AU  - Jan Preiss
AU  - Andrea Stallmach
AU  - Thomas Liceni
AU  - Olaf Grip
AU  - Jonas Halfvarson
AU  - Dharmaraj Durai
AU  - Fraser Cummings
AU  - Christian Seilinger
AU  - Miles Parkes
AU  - James Lindsay
AU  - Guy Lambrecht
AU  - Philippe Van Hootegem
AU  - Jean-François Rahier
AU  - Marie Dewitte
AU  - Xavier Hebuterne
AU  - Elise Chanteloup
AU  - Romain Altwegg
AU  - Stephane Nancey
AU  - Guillaume Bouguen
AU  - Guillaume Pineton de Chambrun
AU  - Floriant Poullenot
AU  - Xavier Roblin
PY  - 2023
JO  - The Lancet Gastroenterology &amp; Hepatology
DO  - 10.1016/s2468-1253(22)00385-5
UR  - https://doi.org/10.1016/s2468-1253(22)00385-5
ER  -

APA

Louis, E., Resche-Rigon, M., Laharie, D., Satsangi, J., Ding, N., Siegmund, B., D'Haens, G., Picon, L., Bossuyt, P., Vuitton, L., Irving, P., Viennot, S., Lamb, C. A., Pollok, R., Baert, F., Nachury, M., Fumery, M., Gilletta, C., Almer, S., Ben-Horin, S., Bouhnik, Y., Colombel, J., Hertervig, E., Andrews, J., Sparrow, M., Leong, R., Connor, S., Radforth-Smith, G., Cruz, P. D., Preiss, J., Stallmach, A., Liceni, T., Grip, O., Halfvarson, J., Durai, D., Cummings, F., Seilinger, C., Parkes, M., Lindsay, J., Lambrecht, G., Hootegem, P. V., Rahier, J., Dewitte, M., Hebuterne, X., Chanteloup, E., Altwegg, R., Nancey, S., Bouguen, G., Chambrun, G. P. D., Poullenot, F., & Roblin, X. (2023). Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(22)00385-5

Source records

crossref · retrieved 2026-09-26T00:21:06.944Z